The Disease/Treatment Axis: Basin-Acting Cures vs Suppression-Only Relapse

A pathological immune state is a latched basin of the same bistable switch, so a durable treatment must move the system ACROSS the saddle-node (basin-acting), not merely hold the drive down (suppression-only). Re-tolerization, tolerance induction, reconstitution and latch-break are the durable class; suppression refills on withdrawal. DIRECTION/CLASS only, not medical advice. Grade [V].

Across six disease classes the substrate gives one verdict: a basin-acting intervention is the durable class and drive-suppression-only relapses on withdrawal. The autoimmune break latches past the spinodal (residual autoreactive occupancy 0.98 after the insult clears); a transient re-tolerization pulse empties it durably (final autoreactive fraction 0.00) while a sub-critical suppressor only contains it and refills on withdrawal (0.99). The same contrast recurs in transplantation (durable induction trajectory 0.00 vs indefinite-immunosuppression rejection 1.00), in lineage-targeted autoimmune cytopenia (lineage output restored to 96% durably vs 14% after suppression is withdrawn), and in systemic inflammation, where the cytokine latch self-sustains after the trigger is removed (supra-threshold 100% vs sub-threshold 0% occupancy) and the break is time-critical.

One landscape, many diseases

The earlier chapters established that an immune commitment — a selected clone, a memory state, an inflamed tissue — is a basin of a bistable R19 switch separated from its resting state by a saddle-node at the spinodal. This chapter collects the disease counterpart: many named immune diseases are the SAME switch latched in the wrong basin, and their treatments fall into exactly two mechanical classes. A basin-acting intervention moves the system across the saddle-node into the other basin, so the change persists after the intervention is withdrawn. A suppression-only intervention merely lowers the drive without crossing the saddle-node, so it holds the state down while applied but the basin refills the moment the pressure is released. The whole chapter is one measured statement: across every disease class, the basin-acting class is the durable one.

The six disease classes, one page each

Each disease class is treated in full on its own self-contained, answer-first page; follow the links for the measured numbers, grades and boundaries:

• Autoimmunity — the tolerance break past the spinodal and its durable cure by therapeutic re-tolerization.
• Transplantation — allo-tolerance induction versus indefinite immunosuppression, and the induction window.
• Allergy — dose×repetition sensitization, the latch, and controlled desensitization.
• Immunodeficiency — one surveillance lever, two diseases, and threshold-gated reconstitution.
• Autoimmune cytopenia — the attack read out on a blood count, durable restoration versus re-collapse.
• Systemic inflammation — the self-sustaining cytokine latch and the time-critical break window.

The organizing claim

Six disease classes, one verdict. In every case the durable intervention is the one that moves the system ACROSS the saddle-node — re-tolerization of an autoreactive clone, induction of allo-tolerance, threshold-crossing immune reconstitution, and the active break of a self-sustaining inflammatory latch. In every case drive-suppression-only is preventive-not-curative: it contains the state while applied, but the basin refills on withdrawal. This is why chronic immunosuppression in autoimmunity and transplantation manages rather than cures, why partial reconstitution fails below threshold, and why removing a trigger does not stop an established cytokine storm. The substrate names the class of durable intervention and the relapse failure mode mechanically, from one bistable switch.

What this is — and is not

This is a re-description of well-known immune-disease and treatment dynamics in the R19 formalism, and a principled statement of treatment DIRECTION and CLASS with its boundaries (the induction window, the reconstitution threshold, the break window). It is NOT a drug, a dose, a schedule, a clinical protocol, or a recommendation for any individual; those require pharmacology, biomarkers and trials outside the deterministic substrate, and every absolute and clinical scale here is left [O] with the obstacle stated. It is NOT a validation of VP theory, and NOT medical advice. The measured content is the qualitative dynamics — the saddle-node thresholds, the durable-versus-relapsing contrast, the windows and the one-lever-two-diseases structure — each graded [V] and reproduced deterministically from the same kernel as the rest of this volume.